In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Calumet Inc (NASDAQ: CLMT) closed at $20.13 in the last session, up 1.82% from day before closing price of $19.77. In other words, the price has increased by $1.82 from its previous closing price. On the day, 1.27 million shares were traded. CLMT stock price reached its highest trading level at $20.16 during the session, while it also had its lowest trading level at $19.63.
Ratios:
We take a closer look at CLMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 1.13.
Upgrades & Downgrades
In the most recent recommendation for this company, TD Cowen on November 11, 2025, Reiterated its Hold rating but revised its target price to $18 from $15 previously.
On May 13, 2025, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.
UBS Upgraded its Sell to Neutral on March 17, 2025, whereas the target price for the stock was revised from $15 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’25 when DANIEL J SAJKOWSKI 2011 TRUST bought 2,000 shares for $15.76 per share.
Morical Gregory J sold 25,123 shares of CLMT for $419,303 on Jun 16 ’25. The SVP, GENERAL COUNSEL now owns 39,415 shares after completing the transaction at $16.69 per share. On Jun 16 ’25, another insider, Straumins Jennifer, who serves as the Director of the company, sold 100,000 shares for $16.23 each. As a result, the insider received 1,623,000 and left with 934,589 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLMT now has a Market Capitalization of 1746364416 and an Enterprise Value of 4199964416. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43. Its current Enterprise Value per Revenue stands at 1.038 whereas that against EBITDA is 12.021.
Stock Price History:
The Beta on a monthly basis for CLMT is 1.23, which has changed by -0.09103447 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, CLMT has reached a high of $23.20, while it has fallen to a 52-week low of $7.68. The 50-Day Moving Average of the stock is 3.39%, while the 200-Day Moving Average is calculated to be 24.45%.
Shares Statistics:
According to the various share statistics, CLMT traded on average about 703.72K shares per day over the past 3-months and 693030 shares per day over the past 10 days. A total of 86.75M shares are outstanding, with a floating share count of 67.46M. Insiders hold about 22.24% of the company’s shares, while institutions hold 52.52% stake in the company. Shares short for CLMT as of 1765756800 were 7868613 with a Short Ratio of 11.18, compared to 1763078400 on 8357691. Therefore, it implies a Short% of Shares Outstanding of 7868613 and a Short% of Float of 11.4700004.
Earnings Estimates
The market rating for Calumet Inc (CLMT) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.15 and -$0.15 for the fiscal current year, implying an average EPS of -$0.15. EPS for the following year is $0.03, with 1.0 analysts recommending between $0.03 and $0.03.
Revenue Estimates
According to 6 analysts, . The current quarter’s revenue is expected to be $1.06B. It ranges from a high estimate of $1.25B to a low estimate of $798.2M. As of . The current estimate, Calumet Inc’s year-ago sales were $949.5MFor the next quarter, 6 analysts are estimating revenue of $1.03B. There is a high estimate of $1.12B for the next quarter, whereas the lowest estimate is $908.6M.
A total of 6 analysts have provided revenue estimates for CLMT’s current fiscal year. The highest revenue estimate was $4.52B, while the lowest revenue estimate was $3.9B, resulting in an average revenue estimate of $4.19B. In the same quarter a year ago, actual revenue was $4.19BBased on 6 analysts’ estimates, the company’s revenue will be $4.25B in the next fiscal year. The high estimate is $5.05B and the low estimate is $3.22B.
